Bio-Rad Laboratories, Inc. Files Routine 8-K
Ticker: BIO-B · Form: 8-K · Filed: Jun 30, 2025 · CIK: 12208
| Field | Detail |
|---|---|
| Company | Bio-Rad Laboratories, Inc. (BIO-B) |
| Form Type | 8-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, routine-filing
Related Tickers: BIO
TL;DR
BIO files standard 8-K, no major news.
AI Summary
On June 30, 2025, Bio-Rad Laboratories, Inc. filed an 8-K report. The filing indicates no specific material events or new information beyond routine disclosures. The company's principal executive offices are located at 1000 Alfred Nobel Drive, Hercules, California.
Why It Matters
This filing is a standard disclosure, indicating no significant new events or material changes for Bio-Rad Laboratories, Inc. as of June 30, 2025.
Risk Assessment
Risk Level: low — The filing is a routine 8-K with no disclosed material events, suggesting no immediate new risks.
Key Players & Entities
- BIO-RAD LABORATORIES, INC. (company) — Registrant
- June 30, 2025 (date) — Date of Report
- 1000 Alfred Nobel Drive, Hercules, California 94547 (location) — Principal executive offices
FAQ
What is the purpose of this 8-K filing for Bio-Rad Laboratories, Inc.?
This 8-K filing serves as a current report to disclose any material events that have occurred or are expected to occur, as required by the SEC.
When was this 8-K report filed by Bio-Rad Laboratories, Inc.?
The report was filed on June 30, 2025.
What is the principal executive office address for Bio-Rad Laboratories, Inc.?
The principal executive offices are located at 1000 Alfred Nobel Drive, Hercules, California 94547.
What is the Commission File Number for Bio-Rad Laboratories, Inc.?
The Commission File Number is 1-7928.
Does this filing indicate any specific material events for Bio-Rad Laboratories, Inc.?
Based on the provided text, this filing is a routine 8-K and does not specify any particular material events beyond its status as a current report.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding BIO-RAD LABORATORIES, INC. (BIO-B).